Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed to activate the GHRH receptor and stimulate endogenous GH release patterns. It is used in research to investigate the growth hormone axis with a physiologically oriented upstream signal rather than direct GH administration.
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed to activate the GHRH receptor and stimulate endogenous GH release patterns. It is used in research to investigate the growth hormone axis with a physiologically oriented upstream signal rather than direct GH administration.
Mechanistic studies focus on pulsatile GH secretion behaviour, downstream IGF-1 signalling, and metabolic endpoints influenced by GH-axis activity. Research designs typically quantify endocrine marker trajectories and receptor responsiveness, assessing how GHRH analogue stimulation influences body composition signalling pathways and metabolic regulation under controlled conditions.
